This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
2 Apr 2013

Hammersmith gets local connection rule

London local authority restricts social housing.



Yet another London borough authority has moved to stem the flow of people applying for social housing, with only those with a five-year connection to the local area permitted access to subsidised homes.
According to Hammersmith and Fulham council, new sanctions will be put into place in order to prioritise "local homes for local people", with a residency test being introduced as part of the application process.
The district follows an example set by Kensington and Chelsea, which last month stated that only vulnerable parties from local areas will be offered social tenancies and terminated lifetime contracts.
Prime minister David Cameron last week advocated the changes and told local authorities all over the country that they should be implementing the same measures in an attempt to control social housing waiting lists, which have been spinning out of control.
Councillor Andrew Johnson, the council's cabinet member for housing, said: “It cannot be fair for decent, honest people to sit on a council housing register for years and years and then see their housing dreams turn to dust when a new migrant, or someone from elsewhere in the country overtakes them in the queue."
The council stated that one person had been on the list for social housing for 36 years, while last year just 470 new lettings were made. It is hoped that adjustments to housing policy will avoid situations like these.
"Hammersmith and Fulham Council is … changing the rules so that local people with a five year connection to the borough come first," Mr Johnson concluded.
The local authority is currently constructing homes to add to its extensive portfolio of social housing, having started up its own company last year to deal with an influx of applications for affordable housing.
It hopes to have completed 500 low-cost units within the next ten years.
 

Related News

  • News Federal judge blocks Colorado's unprecedented price cap on Amgen's Enbrel

    A US federal court has halted Colorado's attempt to impose a US$31,200 annual price cap on Amgen's arthritis drug Enbrel, ruling that the pharmaceutical company would likely suffer irreparable harm. The decision represents a significant blow to...
  • News Protecting life-saving therapies: CPHI Online Podcast Series

    The latest episode of the CPHI Podcast Series dives into a critical challenge facing the pharmaceutical industry: ensuring the integrity of temperature-sensitive medications and biologics through advanced predictive technology.

  • News 2026 Outsourcing Outlook Update - pharma at a crossroads

    The pharmaceutical contract development and manufacturing organisation (CDMO) sector is experiencing unprecedented transformation, driven by evolving therapeutic complexities, geopolitical tensions, and the growing demand for specialised manufacturing ...
  • News Roche maintains German investment commitment whilst rivals scale back

    Pharmaceutical giant Roche has reaffirmed its commitment to investing in Germany, standing firm even as competitors Eli Lilly and Boehringer Ingelheim dramatically reduce their planned investments in response to controversial healthcare reforms.

  • News Women in Pharma: The History of CPHI Women in Japan

    Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive.
  • News EU drafts deal to end essential medicines shortage

    European negotiators have agreed new legislation to tackle persistent shortages of essential medicines by prioritising supply security over price in public procurement and supporting domestic pharmaceutical manufacturing with strategic funding.

  • News Thermo Fisher Scientific offloads microbiology business to PE firm Astorg

    The life sciences giant is divesting its global microbiology unit, which generated $645 million in revenue last year, to the pan-European private equity firm as part of an active portfolio management strategy. The transaction is expected to close in th...
  • News The Shift: Why Sustainability is Moving to the Centre of CPHI Milan 2026

    CPHI Online contributor David Roach takes a look at how conversations around sustainability in the pharmaceutical industry can and must be transformed into actionable deliveries, and what the inaugural CPHI Sustainability Summit means for the industry.